REFRACTORY AML

Clinical trials for REFRACTORY AML explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY AML trials appear

Sign up with your email to follow new studies for REFRACTORY AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 1

Experimental Cell-Drug combo takes on tough leukemia

Disease control Ongoing

This early-phase trial is testing whether a new immune cell therapy called CART123, given together with the drug ruxolitinib, is safe for people with acute myeloid leukemia (AML) that has come back or not responded to treatment. The study will enroll 12 adults who have no other c…

Matched conditions: REFRACTORY AML

Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control

Last updated Jun 27, 2026 08:11 UTC

REFRACTORY AML

Get alerted when new REFRACTORY AML trials appear

Experimental Cell-Drug combo takes on tough leukemia